ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Longitudinal Changes over 10 years in Free Testosterone among HIV-infected and HIV-uninfected Men.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 23895" data-attributes="member: 3"><p>SLAMA, Laurence; JACOBSON, Lisa P.; LI, Xiuhong; PALELLA, Frank J. Jr; MARGOLICK, Joseph B; KINGSLEY, Lawrence A.; WILEY, Dorothy J.; PIALOUX, Gilles; DOBS, Adrian S.; BROWN, Todd T; for the Multicenter AIDS Cohort Study (MACS)</p><p></p><p>JAIDS Journal of Acquired Immune Deficiency Syndromes</p><p>Post Acceptance: August 2015</p><p>Background: Aging in males is associated with lower testosterone levels and a decrease in diurnal variation of testosterone secretion. Cross-sectional studies have shown lower than expected testosterone levels among HIV-infected men, but whether age-related changes in serum testosterone differ by HIV serostatus is not known.</p><p></p><p></p><p>Methods: HIV-infected men from the Multicenter AIDS Cohort Study (MACS), age >= 45 years at highly active antiretroviral therapy initiation, who had >= 2 samples from the subsequent 10 years, were matched to HIV-uninfected men by age, race, MACS site, and calendar time of samples. Linear mixed effects regression models were used to determine whether free testosterone (FT) and its rate of change differed by HIV serostatus.</p><p></p><p></p><p>Results: 182 HIV-infected and 267 HIV-uninfected men were included: median age 48.8 years (Interquartile range (IQR); 45.8, 53.4), median numbers of FT measurements per participant 4 (IQR; 3, 5), 65% were drawn in the AM. Mean adjusted FT levels were lower among HIV-infected than HIV-uninfected men in AM samples (-6.1 ng/dL (95% CI: -9.8, -2.4), p=0.001), but not in PM samples (-1.7 ng/dL (-6.0, 2.6), p=0.441). The rate of FT decline with age did not differ by HIV serostatus: 9.2 ng/dL (95% CI: -13.4, -5.0) per 10 years for HIV- infected vs. 7.9 ng/dL (95% CI: -10.2, -5.5) for HIV-uninfected men, p = 0.578.</p><p></p><p></p><p>Conclusion: FT decreased similarly with increasing age regardless of HIV serostatus. The lower AM, but not PM, FT levels among HIV-infected men compared to HIV-uninfected men suggests a loss of diurnal variation in FT among HIV-infected men.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 23895, member: 3"] SLAMA, Laurence; JACOBSON, Lisa P.; LI, Xiuhong; PALELLA, Frank J. Jr; MARGOLICK, Joseph B; KINGSLEY, Lawrence A.; WILEY, Dorothy J.; PIALOUX, Gilles; DOBS, Adrian S.; BROWN, Todd T; for the Multicenter AIDS Cohort Study (MACS) JAIDS Journal of Acquired Immune Deficiency Syndromes Post Acceptance: August 2015 Background: Aging in males is associated with lower testosterone levels and a decrease in diurnal variation of testosterone secretion. Cross-sectional studies have shown lower than expected testosterone levels among HIV-infected men, but whether age-related changes in serum testosterone differ by HIV serostatus is not known. Methods: HIV-infected men from the Multicenter AIDS Cohort Study (MACS), age >= 45 years at highly active antiretroviral therapy initiation, who had >= 2 samples from the subsequent 10 years, were matched to HIV-uninfected men by age, race, MACS site, and calendar time of samples. Linear mixed effects regression models were used to determine whether free testosterone (FT) and its rate of change differed by HIV serostatus. Results: 182 HIV-infected and 267 HIV-uninfected men were included: median age 48.8 years (Interquartile range (IQR); 45.8, 53.4), median numbers of FT measurements per participant 4 (IQR; 3, 5), 65% were drawn in the AM. Mean adjusted FT levels were lower among HIV-infected than HIV-uninfected men in AM samples (-6.1 ng/dL (95% CI: -9.8, -2.4), p=0.001), but not in PM samples (-1.7 ng/dL (-6.0, 2.6), p=0.441). The rate of FT decline with age did not differ by HIV serostatus: 9.2 ng/dL (95% CI: -13.4, -5.0) per 10 years for HIV- infected vs. 7.9 ng/dL (95% CI: -10.2, -5.5) for HIV-uninfected men, p = 0.578. Conclusion: FT decreased similarly with increasing age regardless of HIV serostatus. The lower AM, but not PM, FT levels among HIV-infected men compared to HIV-uninfected men suggests a loss of diurnal variation in FT among HIV-infected men. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Longitudinal Changes over 10 years in Free Testosterone among HIV-infected and HIV-uninfected Men.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top